share_log

微創醫療：股份發行人截至二零二四年二月二十九日的證券變動月報表

MICROPORT: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 5 03:35
Summary by Moomoo AI
微創醫療科學有限公司於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年2月29日的資料。報告顯示，公司的法定/註冊股本在該月份保持不變，結存為5,000,000,000股，每股面值0.00001美元，總額為50,000美元。此外，公司的股份期權計劃中，購股權計劃的股份期權數目維持在87,128,441股，而另一購股權計劃則有267,609股股份期權被註銷，本月底結存為72,863,968股。股份計劃的股份期權數目則保持在19,156,102股。公司亦披露了兩項可換股票據的資料，分別為2026年到期的零息可換股債券和2028年到期的5.75%可換股債券，發行總額分別為4.48億美元和2.2億美元，並未在本月內發生變動。報告最後確認，所有證券的發行均已獲得董事會的正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
微創醫療科學有限公司於2024年3月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年2月29日的資料。報告顯示，公司的法定/註冊股本在該月份保持不變，結存為5,000,000,000股，每股面值0.00001美元，總額為50,000美元。此外，公司的股份期權計劃中，購股權計劃的股份期權數目維持在87,128,441股，而另一購股權計劃則有267,609股股份期權被註銷，本月底結存為72,863,968股。股份計劃的股份期權數目則保持在19,156,102股。公司亦披露了兩項可換股票據的資料，分別為2026年到期的零息可換股債券和2028年到期的5.75%可換股債券，發行總額分別為4.48億美元和2.2億美元，並未在本月內發生變動。報告最後確認，所有證券的發行均已獲得董事會的正式授權批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Micro-Chung Medical Sciences Limited filed with Hong Kong Trading and Settlement Limited on 5 March 2024 with Hong Kong Trading and Settlement Limited, covering data for the year ended 29 February 2024. The report showed that the company's regulated/registered share capital remained unchanged during the month, depositing 5,000,000,000 shares with a face value of $0.00001 per share for a total of $50,000. IN ADDITION, THE NUMBER OF SHARE OPTIONS UNDER THE SHARE OPTION PLAN OF THE COMPANY REMAINED AT 87,128,441 SHARES, WHILE THE OTHER SHARE OPTION PLAN HAD 267,609 SHARE OPTIONS WRITTEN OFF, AMOUNTING TO 72,863,968 SHARES AT THE END OF THE MONTH. The number of stock options under the share plan remains at 19,156,102 shares. The Company also disclosed information on two convertible notes, zero-yield convertible...Show More
Micro-Chung Medical Sciences Limited filed with Hong Kong Trading and Settlement Limited on 5 March 2024 with Hong Kong Trading and Settlement Limited, covering data for the year ended 29 February 2024. The report showed that the company's regulated/registered share capital remained unchanged during the month, depositing 5,000,000,000 shares with a face value of $0.00001 per share for a total of $50,000. IN ADDITION, THE NUMBER OF SHARE OPTIONS UNDER THE SHARE OPTION PLAN OF THE COMPANY REMAINED AT 87,128,441 SHARES, WHILE THE OTHER SHARE OPTION PLAN HAD 267,609 SHARE OPTIONS WRITTEN OFF, AMOUNTING TO 72,863,968 SHARES AT THE END OF THE MONTH. The number of stock options under the share plan remains at 19,156,102 shares. The Company also disclosed information on two convertible notes, zero-yield convertible notes maturing 2026 and 5.75% convertible notes maturing in 2028, totaling $4.48 million and $2.2 billion respectively, with total issuance of US$4.8 billion and US$2.2 billion, respectively, unchanged during the month. THE REPORT FINALLY CONFIRMS THAT ALL ISSUANCES HAVE BEEN FORMALLY AUTHORISED BY THE BOARD OF DIRECTORS AND COMPLY WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more